Viewing Study NCT03961893


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2025-12-27 @ 1:32 AM
Study NCT ID: NCT03961893
Status: COMPLETED
Last Update Posted: 2023-06-23
First Post: 2019-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Panoramic Screening by Complete Colonoscopy in the Management of Colorectal Adenomas
Sponsor: Institut Paoli-Calmettes
Organization:

Study Overview

Official Title: Panoramic Screening by Complete Colonoscopy in the Management of Colorectal Adenomas
Status: COMPLETED
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: G-EYE-ADR
Brief Summary: Colonoscopy is the gold standard for colorectal cancer prevention by allowing the resection of superficial colorectal adenomas or adenocarcinomas. This protection, more effective in the left colon than in the right colon, is imperfect and there are some adenomas and cancers omitted during colonoscopy. The G-EYE colonoscope equipped with an integrated distal balloon would better unfold the haustrations and stabilize the endoscope. Thus, the detection rate of adenomas would be improved by this better vision. The main objective of this study is to confirm that the use of the G-EYE colonoscope allows better detection of adenomatous polyps, decrease the rate of omitted adenomes and then is more effective.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2018-A03292-53 OTHER ANSM View